申请人:Clark B. Roger
公开号:US20080051415A1
公开(公告)日:2008-02-28
Disclosed are novel piperazine derivatives that act as agonists of the α7 nAChR. Also disclosed are pharmaceutical compositions, methods of treating inflammatory conditions, methods of treating CNS disorders, methods for inhibiting cytokine release from mammalian cells and methods for the preparation of the novel compounds.
本发明涉及一种新的哌嗪衍生物,其作为α7 nAChR的激动剂。同时还揭示了制药组合物,治疗炎症疾病的方法,治疗中枢神经系统疾病的方法,抑制哺乳动物细胞细胞因子释放的方法以及制备新化合物的方法。